Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today.
CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022, if late-stage clinical trials are successful.
The total number of vaccines ordered by the Government is based on a two-dose per person regime.
